Vimarsana
Biggest News Aggregation in the World

Page 4 - Cause Mortality News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cause Mortality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cause Mortality Today - Breaking & Trending Today

Did lockdowns cause increased mortality rates? -- Society's Child -- Sott.net - Vimarsana News

Did lockdowns cause increased mortality rates? -- Society's Child -- Sott.net

Emerging statistics on excess mortality rates paint an alarming picture. Far more people died in 2021, after the rollout of the COVID shots, and in 2022, than during the height of the COVID pandemic in 2020. I will review some of those shocking...

Source: sott.net
Did Lockdowns Cause Increased Mortality Rates? - Vimarsana News

Did Lockdowns Cause Increased Mortality Rates?

Emerging statistics paint an alarming picture - far more have died after the rollout of this 'super potion' ...

50 States of New All-Cause Death Data for January 2022 - Vimarsana News

50 States of New All-Cause Death Data for January 2022

The new numbers raise new questions about how retirement specialists should think about longevity.

Cidara Therapeutics and Mundipharma Announce Positive Topline Results from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis - Vimarsana News

Cidara Therapeutics and Mundipharma Announce Positive Topline Results from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

For Trade and Medical Media Only Trial met FDA and EMA-pre-specified primary endpoints versus daily standard of care Data to support global regulatory filings in mid-2022 Cidara to host investor

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update - Vimarsana News

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Share this article Share this article DUBLIN, Feb. 23, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the fourth quarter and full year ended December 31, 2020. "2020 was a critical year of growth for YUPELRI, with our commercial team persevering during a respiratory pandemic and driving increased market share," said Rick E Winningham, Chief Executive Officer. "This same resilience was seen across our organization, laying the foundation for this year's clinical development milestones for ampreloxet...